In vivo reprogramming towards pluripotency for tissue repair and regeneration

Kostas Kostarelos, Irene de Lázaro

Research output: Chapter in Book/Conference proceedingChapterpeer-review

Abstract

The generation of pluripotent-like, proliferative cells within an injured, aged or degenerated tissue via direct in vivo reprogramming (OSKM overexpression) has been proposed as a new therapeutic avenue to tackle conditions in which the regenerative capabilities of the organism cannot cope with the magnitude of cell loss. Thanks to their capacity to proliferative and to re-differentiate into mature phenotypes, in vivo reprogrammed cells could act as an in situ source of replacement cells, avoiding the challenges associated to ex vivo cell therapy. In this Chapter, we discuss this and other opportunities offered by the in vivo overexpression of reprogramming factors (OSKM) and analyse the challenges ahead of the clinical translation of this strategy. Encouraging, yet scarce, studies that confirm enhanced regeneration following in vivo OSKM overexpression in different models of tissue injury are also discussed, with special focus on induction schemes specifically designed to avoid tumorigenesis.
Original languageEnglish
Title of host publicationIn Vivo Reprogramming in Regenerative Medicine
EditorsAçelya Yilmazer
PublisherHumana Press
Pages83-98
ISBN (Print)978-3-319-65719-6
Publication statusPublished - 2017

Publication series

NameIn Vivo Reprogramming in Regenerative Medicine

Fingerprint

Dive into the research topics of 'In vivo reprogramming towards pluripotency for tissue repair and regeneration'. Together they form a unique fingerprint.

Cite this